Related references
Note: Only part of the references are listed.The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma
Zubin Zhang et al.
ANTI-CANCER DRUGS (2013)
Cooperation between Classical and Alternative NF-κB Pathways Regulates Proinflammatory Responses in Epithelial Cells
Jane E. Tully et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
3,5-Disubstituted Thiadiazine-2-thiones: New Cell-Cycle Inhibitors
Awwad A. Radwan et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma
Claire Fabre et al.
CLINICAL CANCER RESEARCH (2012)
A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo
Chunhua Ling et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway
Xinliang Mao et al.
BLOOD (2011)
A critical role for the NFkB pathway in multiple myeloma
Yulia N. Demchenko et al.
ONCOTARGET (2010)
Cyproheptadine displays preclinical activity in myeloma and leukemia
Xinliang Mao et al.
BLOOD (2008)
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal. degradation through up-regulation of ubiquitin
Xinliang Mao et al.
BLOOD (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
NF-κB and IKK as therapeutic targets in cancer
HJ Kim et al.
CELL DEATH AND DIFFERENTIATION (2006)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells
YJ Lou et al.
LEUKEMIA RESEARCH (2005)
Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis
LM Fidalgo et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2004)
Cell type-specific expression of the IκB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-κB activation
JA Gustin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells
J Hu et al.
CARCINOGENESIS (2004)
Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription
H Buss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Essential role of RelA Ser311 phosphorylation by ζPKC in NF-κB transcriptional activation
A Duran et al.
EMBO JOURNAL (2003)
IKKβ plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide
F Yang et al.
JOURNAL OF IMMUNOLOGY (2003)
Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)
L Vermeulen et al.
EMBO JOURNAL (2003)
The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1
HH Zhong et al.
MOLECULAR CELL (2002)
Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II
D Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Proteasome inhibitors as anti-cancer agents
RZ Murray et al.
ANTI-CANCER DRUGS (2000)
Share Paper
